Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
The American Journal of Medicine|November 16, 2004
Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemiaMaria Del Ben, Marco Burattin, Marcello Arca, et al.
Giornale Italiano Di Cardiologia (2006)|April 19, 2024
[STEP-RCV Project - A scientific expert panel for patients at high and very high cardiovascular risk: how to streamline lipid-lowering therapy]Furio Colivicchi, Marcello Arca, Stefania Angela Di Fusco, et al.
International Journal of Molecular Sciences|January 16, 2021
The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?Simone Bini, Laura D'Erasmo, Alessia Di Costanzo, et al.
Atherosclerosis|September 25, 2020
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular featuresStefano Bertolini, Sebastiano Calandra, Marcello Arca, et al.
Atherosclerosis. Supplements|February 16, 2021
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemiaMarta Gazzotti, Manuela Casula, Elena Olmastroni, et al.
The Journal of Pediatrics|January 21, 2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and AdolescentsAlessia Di Costanzo, Francesco Massimo Perla, Laura D'Erasmo, et al.
Current Atherosclerosis Reports|May 28, 2020
Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical TrialsFederica Fogacci, Giuseppe Danilo Norata, Peter P Toth, et al.
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2026
Replay: Refining the Hepatic Risk Interpretation in APOB Loss-Of-FunctionAlessia Di Costanzo, Ilaria Pirona, Ilenia Minicocci, et al.
Acta Diabetologica|November 3, 2016
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literatureDavide Noto, Marcello Arca, Patrizia Tarugi, et al.
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
The American Journal of Medicine|November 16, 2004
Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemiaMaria Del Ben, Marco Burattin, Marcello Arca, et al.
Giornale Italiano Di Cardiologia (2006)|April 19, 2024
[STEP-RCV Project - A scientific expert panel for patients at high and very high cardiovascular risk: how to streamline lipid-lowering therapy]Furio Colivicchi, Marcello Arca, Stefania Angela Di Fusco, et al.
International Journal of Molecular Sciences|January 16, 2021
The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?Simone Bini, Laura D'Erasmo, Alessia Di Costanzo, et al.
Atherosclerosis|September 25, 2020
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular featuresStefano Bertolini, Sebastiano Calandra, Marcello Arca, et al.
Atherosclerosis. Supplements|February 16, 2021
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemiaMarta Gazzotti, Manuela Casula, Elena Olmastroni, et al.
The Journal of Pediatrics|January 21, 2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and AdolescentsAlessia Di Costanzo, Francesco Massimo Perla, Laura D'Erasmo, et al.
Current Atherosclerosis Reports|May 28, 2020
Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical TrialsFederica Fogacci, Giuseppe Danilo Norata, Peter P Toth, et al.
Atherosclerosis|September 7, 2015
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approachIlenia Minicocci, Cristina Prisco, Anna Montali, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2026
Replay: Refining the Hepatic Risk Interpretation in APOB Loss-Of-FunctionAlessia Di Costanzo, Ilaria Pirona, Ilenia Minicocci, et al.
Acta Diabetologica|November 3, 2016
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literatureDavide Noto, Marcello Arca, Patrizia Tarugi, et al.
Pageof 22